At a glance
ClinicalIndex Comparison RecordN/ACompleted· 390 enrolled
Drug / intervention
Pantoprazole +5 moredrug
Likely dose
Pantoprazole 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare 10-day Sequential Therapy and 14-day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
In Brief
A clinical study evaluating Pantoprazole, Amoxicillin, and 4 other interventions for Helicobacter Pylori Infection. Completed, enrolled 390 participants across 1 site.
Detailed Summary
1. To compare 10-day sequential therapy and 14-day modified bismuth quadruple therapy and to establish more effective first-line regimen for the eradication of Helicobacter pylori in Korea. 2. To evaluate the effect of H. pylori eradication therapy on the symptom improvement of functional dyspepsia
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHelicobacter Pylori Infection
CountriesSouth Korea
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartJul 2014
Primary CompletionMay 2015
Study CompletionApr 2016
TodayJul 2026
First PostedJun 10, 2014
Enrollment StartJul 1, 2014
Primary CompletionMay 1, 2015
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 12.1 years ago
Interventions
Pantoprazoledrug
Pantoprazole 40mg bid
Amoxicillindrug
Amoxicillin 1000mg bid
Clarithromycindrug
Clarithromycin 500mg bid
Metronidazoledrug
Metronidazole 500mg tid
Tetracyclinedrug
Tetracycline 1000mg bid
Bismuthdrug
Bismuth 600mg bid